Insight

GLP-1s lowers risk of 10 obesity-associated cancers

Photo taken from medicalnewstoday.com

Jul 9, 2024, 10:44

GLP-1s lowers risk of 10 obesity-associated cancers

Ron DePinho, Professor and Past President of MD Anderson Cancer Center, shared a post on X:

“HUGE NEWS: GLP-1s lowered risk of 10 obesity-associated cancers. Compared to insulin, GLP-1s decreased in 10 of 13 cancers – 65% reduction in gallbladder cancer, 59% in pancreatic cancer, and 53% in hepatocellular carcinoma.”

Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes

Authors: Lindsey Wang, Rong Xu, David C. Kaelber and Nathan A. Berger.

Source: Ron DePinho/X

cancer David C. Kaelber gallbladder cancer GLP-1s hepatocellular carcinoma Lindsey Wang MD Anderson Cancer Center Nathan A. Berger obesity-associated cancers OncoDaily Oncology Pancreatic Cancer Ron DePinho Rong Xu

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage